Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Acute and Maintenance Intravenous Ketamine for Treatment Resistant Major Depression With Suicidal Ideation/Attempt


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02094898

Organisation Name: Mayo Clinic

Overal Status: Completed

Start Date: September 2014

Last Update: August 11, 2017

Lead Sponsor: Mayo Clinic

Brief Summary: The purpose of this research study was to find out if the medication known as ketamine could help the symptoms of depression. This drug is approved by the U.S. Food and Drug Administration (FDA) as an anesthetic agent; however, it is not approved for use in depression treatment. The FDA allowed the use of this drug in this research study.

Conditions:
  • Depression
  • Suicide


Total execution time in seconds: 0.21969103813171